Novan, Inc. - NOVN
About Gravity Analytica
Recent News
- 03.31.2026 - Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
- 03.19.2026 - Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results
- 03.12.2026 - Pelthos Therapeutics to Present at 38th Annual ROTH Conference
- 03.09.2026 - Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
- 02.23.2026 - Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- 01.13.2026 - Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
- 01.05.2026 - Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
- 12.23.2025 - Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
- 12.04.2025 - Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
- 12.02.2025 - Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference